• Publications
  • Influence
Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial.
OBJECTIVE To assess the efficacy and safety of paroxetine for the treatment of pediatric obsessive-compulsive disorder. METHOD Children (7-11 years of age) and adolescents (12-17 years of age)Expand
  • 169
  • 4